U.S. markets closed

Cardlytics, Inc. (CDLX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
16.50+0.09 (+0.55%)
At close: 04:00PM EDT
16.50 0.00 (0.00%)
After hours: 06:06PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close16.41
Bid16.80 x 800
Ask16.99 x 800
Day's Range16.28 - 17.53
52 Week Range2.57 - 19.57
Avg. Volume741,339
Market Cap622.449M
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)-13.46
Earnings DateOct 30, 2023 - Nov 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CDLX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cardlytics, Inc. Common Stock
    Daily – Vickers Top Buyers & Sellers for 09/12/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    19 days agoArgus Research
View more

    Cardlytics, Immunocore, and More Stocks See Action From Activist Investors

    CAS Investment Partners reached a cooperation agreement with digital-ad platform Cardlytics. General Atlantic trimmed its stake in pharmaceutical firm Immunocore.

  • GlobeNewswire

    Cardlytics Appoints Alex Mishurov to its Board of Directors

    ATLANTA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is excited to announce the appointment of Alex Mishurov as an independent member of its Board of Directors. Mishurov will serve on the Board’s Compensation Committee, Nominating and Corporate Governance Committee and Transaction Committee. In connection with Mishurov’s appointment, Cardlytics entered into a cooperation agreement with CAS Investment Partners, a 14.4% st


    Insider Sell: Cardlytics Inc CEO Karim Temsamani Sells 166,973 Shares

    On September 8, 2023, Karim Temsamani, the CEO of Cardlytics Inc (NASDAQ:CDLX), sold 166,973 shares of the company.